Synthetic biology pioneer Amyris files for Chapter 11 bankruptcy protection

The bankruptcy court filing exposes ongoing financial losses, job cuts and allegations of supply chain and accounting irregularities.
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks